Samsung Biologics Co Ltd
Samsung Biologics's GHG Emissions Data Preview
In 2023, Samsung Biologics completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy), and Scope 3 (indirect emissions across the value chain).
Samsung Biologics has also provided a category-level breakdown for 10 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Samsung Biologics's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Samsung Biologics amounted to 219,698 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Samsung Biologics increased by 33.96%, suggesting that the company faced challenges in reducing its emissions from its core operations.
Samsung Biologics's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Samsung Biologics's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Samsung Biologics were 69,262 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has Samsung Biologics reduced its Scope 1 emissions over time?
Since 2019, Samsung Biologics's Scope 1 emissions have increased by 67.02%, reflecting a rising long-term trend in Scope 1 emissions over time.
Compared to the previous year (2022), Samsung Biologics's Scope 1 emissions increased by 26.91%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.
What are Samsung Biologics's Scope 2 emissions?
In 2023, Samsung Biologics reported Scope 2 greenhouse gas (GHG) emissions of 150,436 tCOâ‚‚e without specifying the calculation method.
Has Samsung Biologics reduced its Scope 2 emissions over time?
Since 2019, Samsung Biologics's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have increased by 77%, reflecting a rising long-term trend in Scope 2 emissions over time.
Compared to the previous year (2022), Samsung Biologics's Scope 2 emissions (Unspecified Calculation Method) rose by 37.48% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy
What methodology does Samsung Biologics use for Scope 2 reporting?
In 2023, Samsung Biologics reported its Scope 2 emissions using an unspecified methodology.
Samsung Biologics's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Samsung Biologics's Value Chain Emissions
In 2023, Samsung Biologics reported 528,480 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.
The 2023 disclosure of Samsung Biologics includes a breakdown across 10 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2022, demonstrating consistent Scope 3 emissions reporting coverage year over year.
Samsung Biologics's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Samsung Biologics's Scope 3 emissions?
In 2023, Samsung Biologics reported total Scope 3 emissions of 528,480 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Approximately 95.77% of these emissions originated from upstream activities such as purchased goods and capital goods, while 4.23% came from downstream activities like product use, distribution, and end-of-life treatment.
Compared to the previous year (2022), Samsung Biologics's Scope 3 emissions decreased by 33.25%, highlighting the company's efforts to lower indirect emissions from its value chain.
What categories of Scope 3 emissions does Samsung Biologics disclose?
In 2023, Samsung Biologics reported emissions for 10 out of the 15 Scope 3 categories defined by the GHG Protocol.
This reflects a high level of granularity and transparency in the company's emissions reporting.
What are the main sources of Samsung Biologics's Scope 3 emissions?
In 2023, the largest contributors to Samsung Biologics's Scope 3 emissions were:
- Purchased Goods and Services (Cat. 1): 416,038 tCOâ‚‚e (78.72%)
- Capital Goods (Cat. 2): 53,958 tCOâ‚‚e (10.21%)
- Processing of Sold Products (Cat. 10): 22,340 tCOâ‚‚e (4.23%)
Samsung Biologics's Scope 3 Emissions by Categories
Insights into Samsung Biologics's Total Carbon Footprint
In 2023, Samsung Biologics reported a total carbon footprint of 748,178 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 21.72% decrease compared to 2022, indicating progress in reducing its overall greenhouse gas output.
The largest contributor to Samsung Biologics's total carbon footprint was Scope 3 emissions, accounting for 70.64% of the company's total carbon footprint, followed by Scope 2 emissions at 20.11%.